Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy.
Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy.
复制标题
DOI:
10.1016/j.yjmcc.2011.01.008
复制
发表时间:
2011-10
影响因子:
5
通讯作者:
Gupta MP
中科院分区:
文献类型:
--
作者:
Sundaresan NR;Pillai VB;Gupta MP
Calorie restriction is considered to be the best environmental intervention providing health benefits to mammals. The underlying mechanism of this intervention seems to be controlled by a group of NAD-dependent deacetylases, collectively called sirtuins. In mammals there are seven sirutuin analogues, SIRT1 to SIRT7. The founding member of this family, SIRT1 is shown to protect cardiomyocytes from apoptosis and age-dependent degeneration in a dose dependent manner—protecting cells at low doses but showing detrimental effects at high doses. Studies performed with over expression or knockdown of SIRT1 indicated that though it protects cells from oxidative stress and ischemia-reperfusion injury, it promotes hypertrophy of cardiomyocytes. Activation of endogenous SIRT1 by resveratrol also displayed pro-survival and pro-hypertrophic activity of SIRT1. In this article we review recent findings documenting the role of SIRT1 in regulating cardiac myocyte growth and survival under stress, and the proposed mechanism behind its cardio protective effects. We also briefly discuss two other sirtuin analogues which have been shown to have cardioprotective effects.